Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis
Stopped early · Not applicable
Conditions studied: Psoriasis
In brief
The purpose of this study is to determine the best dosing strategy when using Excimer Laser to treat plaque-type psoriasis. In this study, half of the body's psoriasis will be treated with a new dosing strategy, and the other half will be treated with the conventional method. We hope to show that the new dosing strategy will result in faster improvement of psoriasis.
Key facts
- Study ID
- NCT02294981
- Run by
- University of California, San Francisco
- People needed
- 4
- Starts
- 2016-01-01
- Expected to finish
- 2017-09-01
- Last updated by the study team
- 2020-06-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of chronic plaque psoriasis for at least 6 months
- Age ≥ 18 years
- Body surface area affected ≤ 10 percent
- Presence of at least one pair of bilateral target lesions with an area of at least 20 cm2 per target lesion. The bilateral target lesions must be present in the same category of anatomical region (e.g., bilateral lower extremities, bilateral upper extremities or bilateral trunk).
You may not qualify if…
- active or past history of erythrodermic psoriasis, guttate psoriasis, or pustular psoriasis
- history of photosensitivity disorder
- history of malignant melanoma
- active, invasive non-melanoma skin carcinoma
- Fitzpatrick Skin Type I
- Subject has received ultraviolet B phototherapy or any topical anti-psoriatic therapy within two weeks prior to starting the study.
- Subject has received systemic or topical psoralen-ultraviolet A photochemotherapy within four weeks prior to starting the study.
- Subject has received biologic therapy within three months of starting the study.
Where it is running
- UCSF Psoriasis Skin and Treatment Center — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.